NICE INSIGHT REPORT

Microbial Fermentation, Biologics: Market Insight, CDMO Pricing and Competitor Benchmarking

Updated Monthly
  • 2025 CDMO pricing data for 101 clinical and commercial microbial biologics development and manufacturing RFP service line items
  • Exhaustive directory of capabilities profiles for the top 44 biologics CDMOs specializing in microbial fermentation
  • Technical focus on the regulatory landscape and manufacturing challenges for biologics, such as GLP-1 and insulin trials, cytokines, and growth factors
  • Includes Nice Insight’s Clinical Trials Landscape tool — an in-depth custom research platform for current and upcoming microbial biologics trials, sourced from the FDA Clinical Trials Database
Learn More
Microbial Fermentation, Biologics

Key market insights for innovators, CDMOs and investors in the biologics industry.

Essential CDMO market intelligence and pricing data

Unlock the biologics market with insights into manufacturing trends and a comprehensive study of the top CDMOs specializing in microbial fermentation of therapeutics. Benchmark your business from development to manufacture with our in-depth pricing studies, which use years of primary data.

 

Analysis of microbial fermentation-based biologics

Our Market Insight report provides unique analyses into biologics produced in microbial cell culture, such as cytokines and growth factors. Hear from Ph.D. scientists, KOLs, and respected market voices discussing the development of microbial fermentation-based biologics and the disruptive technologies forging the future of healthcare.

Update cookies preferences